En español

Office of the DESPR Director (OD)

What We Do:

The mission of the Division of Epidemiology, Services and Prevention Research is to improve the nation's public health by promoting integrated approaches to understand and address interactions between individuals and environments that contribute to the continuum of problems related to drug use. We will develop scientific knowledge with clear applications to practice and public policy.

Staff Biographies for the Office of the Director:

  • Carlos Blanco, M.D., Ph.D. - Division Director
    (301) 443-6504
    Carlos Blanco, M.D., Ph.D., M.S. is the Director of the Division of Epidemiology, Services, and Prevention Research at the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. Dr. Blanco is a national known expert in the epidemiology and treatment of addictive disorders with and without comorbid disorders. His accomplishments include, among others, a detailed examination of the course and stages of substance use disorders, the development of methods to quantify the generalizability of clinical trials, the development and testing of interventions that combine motivational interviewing with cognitive-behavioral therapy to improve retention and outcome in individuals with addictive disorders, and the creation of a virtual map of psychiatric disorders, based on empirical data, to guide research into the causes of mental disorders. Prior to joining NIDA, Dr. Blanco was Professor of Psychiatry at Columbia University Medical Center and a Research Psychiatrist at the New York State Psychiatric Institute. He is a graduate of Universidad Autónoma de Madrid (Spain) and completed his psychiatry residency at Columbia University, where he also completed a research fellowship. Dr. Blanco has authored over 200 peer-reviewed publications.
  • Kevin P. Conway, Ph.D. - Deputy Director
    (301) 443-6504
    Dr. Conway is the Deputy Director of the Division of Epidemiology, Services, and Prevention Research at the National Institute on Drug Abuse (NIDA).  He also serves as the Project Officer for the Population Assessment of Tobacco and Health (PATH) Study, a nationally-representative, longitudinal cohort study of initially 45,971 adults and youth ages 12 years and older in the United States. The PATH Study (www.pathstudyinfo.nih.gov) is the first large-scale NIH-FDA collaboration since Congress gave FDA the authority to regulate tobacco products under the 2009 Family Smoking Protection and Tobacco Control Act.  Prior to joining NIDA in 2001, Dr. Conway was a research faculty member in the Department of Epidemiology and Public Health at the Yale University School of Medicine, where he directed NIH-funded studies and provided research supervision and training to undergraduate and graduate students. Dr. Conway is the author of over 60 publications focusing on the epidemiology of alcohol, tobacco, drug use, co-occurring psychiatric disorders, and violence.  He is a Fellow of the American Psychopathological Association, and is the recipient of numerous awards for leadership in research.  Dr. Conway earned the Ph.D. in Experimental Psychology from Temple University in 1998. 
  • Meyer D. Glantz, Ph.D. - Associate Director for Science
    (301) 443-6504
    Dr. Glantz is currently the Associate Director for Science of the Division of Epidemiology and Prevention Research (DESPR) the National Institute on Drug Abuse, National Institutes of Health and the Chief of the Analytic Unit. At NIDA, Dr. Glantz previously served as the Acting Deputy Director of DESPR and the Chief of the Epidemiology Research Branch and the Director of the Etiology Research Program. Prior to coming to NIDA he worked as a researcher and clinician at the Veterans Administration Clinic in Boston. Dr. Glantz is a Fellow of the American Psychological Association and serves as a consultant to and board member of a variety of scientific and professional organizations and publications. He is the author of numerous articles and chapters on substance abuse, drug abuse etiology, cognitive therapy, prevention, and the elderly and has authored several volumes including Vulnerability to Drug Abuse, Biobehavioral Research Approaches to Drug Abuse Etiology, Resilience and Development: Positive Life Adaptations, and Drug Abuse: Origins and Interventions. In addition, he maintains a private clinical practice in the Washington D.C. area, supervises other clinicians, is a lecturer for the Montgomery County Adult Education program and has taught at several area universities. Dr. Glantz received his doctorate from Harvard University in 1979.
  • Linda Moore - Program Support Assistant
    (301) 443-8769
    Mrs. Moore serves as the administrative assistant for the Office of the Director at the Division of Epidemiology, Services, and Prevention research; assisting with planning and coordination of the division’s logistical operations. Prior to entry into government she worked in the private sector as an Assistant General Manager, and Project Manager in retail and distribution services environments. Mrs. Moore currently serves as Committee Chair for the Work Life Advisory Committee/Employee Development, and Chair elect, and has volunteered for such initiatives as the Combined Federal Campaign (CFC), and NIDA Summer Research Program. Mrs. Moore holds a Master’s degree in Psychology, and Bachelor’s degree in Human Services Management from the University of Phoenix.
  • Clark Tung - Program Support Assistant
    (301) 443-8662
    Clark joined NIDA DESPR as a Program Support Assistant in May 2016. Prior to joining NIH in 2006, Clark was a legal assistant at a real estate law firm. Clark received his Bachelor’s degree in Criminal Justice in 2003 from the University of Maryland, College Park.

This page was last updated March 2017